Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis

Journal of Neuroimmunology

Volumn 144, Issue 1-2, 2003, Pages 105-115

  Hughes, L E ^a   Smith, P A ^b   Bonell, S ^a   Natt, R S ^a   Wilson, C ^a   Rashid, T ^a   Amor, S ^b,c   Thompson, E J ^d   Croker, J ^e   Ebringer, A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Emergency Department   (United Kingdom)

Author keywords

Acinetobacter; Bacteria; Multiple sclerosis; Myelin basic protein; Myelin oligodendrocyte glycoprotein; Pseudomonas

Indexed keywords

3 OXO ADIPATE COA TRANSFERASE SUBUNIT A; 4 CARBOXYMUCONOLACTONE DECARBOXYLASE; ANTIBODY; BACTERIAL PROTEIN; GAMMA CARBOXYMUCONOLACTONE DECARBOXYLASE; ISOENZYME; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ACINETOBACTER; ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MOLECULAR MIMICRY; MOUSE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; STROKE;

EID: 10744219605     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00274-1     Document Type: Article

References (42)

1. Albert L.J., Inman R.D. Molecular mimicry and autoimmunity. N. Engl. J. Med. 341:1999;2068-2074.
2. Amor S., Baker D., Groome N., Turk J.L. Identification of a major encephalitogenic epitope of proteolipid protein (residues 56-70) for the induction of experimental allergic encephalomyelitis in Biozzi AB/H and nonobese diabetic mice. J. Immunol. 150:1993;5666-5672.
3. Amor S., Groome N., Linington C., Morris M.M., Dornmair K., Gardinier M.V., Matthieu J.M., Baker D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:1994;4349-4356.
4. Andersen O., Lygner P.E., Bergstrom T., Andersson M., Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J. Neurol. 240:1993;417-422.
5. Ben-Nun A., Otmy H., Cohen I.R. Genetic control of autoimmune encephalomyelitis and recognition of the critical nonapeptide moiety of myelin basic protein in guinea pigs are exerted through interaction of lymphocytes and macrophages. Eur. J. Immunol. 11:1981;311-316.
6. Buljevac D., Flach H.Z., Hop W.C., Hijdra D., Laman J.D., Savelkoul H.F., van Der Meche F.G., van Doorn P.A., Hintzen R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain. 125:2002;952-960.
7. Correale J., de los Milagros Bassani Molinas M. Time course of T-cell responses to MOG and MBP in patients with clinically isolated syndromes. J. Neuroimmunol. 136:2003;162-171.
8. Ebringer A., Thorpe C., Pirt J., Wilson C., Cunningham P., Ettelaie C. Bovine spongiform encephalopathy: is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? Environ. Health Perspect. 105:1997;1172-1174.
9. Edwards S., Zvartau M., Clarke H., Irving W., Blumhardt L.D. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 64:1998;736-741.
10. Eylar E.H., Caccam J., Jackson J.J., Westall F.C., Robinson A.B. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science. 168:1970;1220-1223.
11. Fujinami R.S. Can virus infections trigger autoimmune disease? J. Autoimmun. 16:2001;229-234.
12. Gay D., Dick G., Upton G. Multiple sclerosis associated with sinusitis: case-controlled study in general practice. Lancet. 1:1986;815-819.
13. Granieri E., Casetta I., Tola M.R., Ferrante P. Multiple sclerosis: infectious hypothesis. Neurol. Sci. 22:2001;179-185.
14. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heidenreich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 114:2001;220-225.
15. Hughes L.E., Bonell S., Natt R.S., Wilson C., Tiwana H., Ebringer A., Cunningham P., Chamoun V., Thompson E.J., Croker J., Vowles J. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in multiple sclerosis: prospects for diagnosis using the myelin-Acinetobacter-neurofilament antibody index. Clin. Diagn. Lab. Immunol. 8:2001;1181-1188.
16. Kaplan M.H., Meyeserian M. An immunological cross-reaction between group A streptococcal cells and human heart tissue. Lancet. i:1962;706-710.
17. Kennel De March A., De Bouwerie M., Kolopp-Sarda M.N., Faure G.C., Bene M.C., Bernard C.C. Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis. J. Neuroimmunol. 135:2003;117-125.
18. Kerlero de Rosbo N., Hoffman M., Mendel I., Yust I., Kaye J., Bakimer R., Flechter S., Abramsky O., Milo R., Karni A., Ben-Nun A. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27:1997;3059-3069.
19. Khalafpour S., Ebringer A., Abuljadayel I., Corbett M. Antibodies to Klebsiella and Proteus micro-organisms in ankylosing spondylitis and rheumatoid arthritis patients measured by ELISA. Br. J. Rheumatol. 27S:1988;86-89.
20. Kohm A.P., Fuller K.G., Miller S.D. Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology. Trends Microbiol. 11:2003;101-105.
21. Lamoureux G., Lapierre Y., Ducharme G. Past infectious events and disease evolution in multiple sclerosis. J. Neurol. 230:1983;81-90.
22. Mazza G., Ponsford M., Lowrey P., Campbell M.J., Zajicek J., Wraith D.C. Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals. Clin. Exp. Immunol. 128:2002;538-547.
23. Newcombe J., Gahan S., Cuzner M.L. Serum antibodies against central nervous system proteins in human demyelinating disease. Clin. Exp. Immunol. 59:1985;383-390.
24. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
25. Rapp N.S., Gilroy J., Lerner A.M. Role of bacterial infection in exacerbation of multiple sclerosis. Am. J. Phys. Med. Rehabil. 74:1995;415-418.
26. Reindl M., Linington C., Brehm U., Egg R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. Brain. 122(Pt 11):1999;2047-2056.
27. Salvetti M., Ristori G., D'Amato M., Buttinelli C., Falcone M., Fieschi C., Wekerle H., Pozzilli C. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur. J. Immunol. 23:1993;1232-1239.
28. Salyers A.A., Whitt D.D. Pseudomonas aeruginosa. Bacterial Pathogenesis: A Molecular Approach. 1994;260-270 ASM Press, Washington, DC.
29. Singleton P., Sainsbury D. Dictionary of Microbiology and Molecular Biology. 2nd ed. 1995;719-720 Wiley, Chichester.
30. Steinman L. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:2001;762-764.
31. Stepaniak J.A., Wolf N.A., Sun D., Swanborg R.H. Interstrain variability of autoimmune encephalomyelitis in rats: multiple encephalitogenic myelin basic protein epitopes for DA rats. J. Neuroimmunol. 78:1997;79-85.
32. Talbot P.J., Arnold D., Antel J.P. Virus-induced autoimmune reactions in the CNS. Curr. Top. Microbiol. Immunol. 253:2001;247-271.
33. Tejada-Simon M.V., Zang Y.C., Hong J., Rivera V.M., Zhang J.Z. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann. Neurol. 53:2003;189-197.
34. Tiwana H., Wilson C., Alvarez A., Abuknesha R., Bansal S., Ebringer A. Cross-reactivity between the rheumatoid arthritis-associated motif EQKRAA and structurally related sequences found in Proteus mirabilis. Infect. Immun. 67:1999;2769-2775.
35. Towner K.J. Clinical importance and antibiotic resistance of Acinetobacter spp. Proceedings of a Symposium Held on 4-5 November 1996 at Eilat, Israel. J. Med. Microbiol. vol. 46:1997;721-746.
36. Villers D., Espaze E., Coste-Burel M., Giauffret F., Ninin E., Nicolas F., Richet H. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:1998;182-189.
37. Wajgt A., Gorny M. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol. Scand. 68:1983;337-343.
38. Warren K.G., Catz I. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients. Ann. Neurol. 21:1987;183-189.
39. Wucherpfennig K.W. Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. 108:2001;1097-1104.
40. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
41. Wucherpfennig K.W., Strominger J.L. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181:1995;1597-1601.
42. Wucherpfennig K.W., Catz I., Hausmann S., Strominger J.L., Steinman L., Warren K.G. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. J. Clin. Invest. 100:1997;1114-1122.